Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 07/13/2025

Top Performing Leveraged/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. MSOX – AdvisorShares MSOS Daily Leveraged ETF MSOX, which seeks to achieve 2x the total daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements, topped the list with a ~40% weekly return. Cannabis stocks saw a boost last week after Trump’s ally suggested the President supports rescheduling cannabis. This move would benefit players in the cannabis industry. 2. ETHU – 2x Ether ETF ETHU ETF, which aims to provide 2x the daily price movements of Ether, ranked second on the Levered/ Inverse ETFs’ list with over 35% weekly gains, driven by reinvigorated institutional demand, significant spot Bitcoin ETF inflows, and rising optimism for worldwide crypto adoption. 3. ETHT – ProShares Ultra Ether ETF ETHT which tracks 2x the daily price movements of an index that measures the price of Ether was another ether-focused ETF on the list with ~35% weekly returns. 4. CONL – GraniteShares 2x Long Coinbase Daily ETF CONL ETF, which provides 2x leveraged exposure to the daily price movement for shares of Coinbase stock, also featured on the list with over ~17% weekly returns. The crypto industry is enjoying multiple boosts this month, thanks to renewed demand and increased inflows. 5. BITU – ProShares Ultra Bitcoin ETF BITU which tracks 2x the daily price movements of an index measuring the price of Bitcoin, ranked among the leveraged ETFs last week. Bitcoin’s recent surge aligned with Congress’s “Crypto Week,” which began on July 14, where lawmakers are set to debate crucial regulations, like the GENIUS Act, potentially shaping the crypto industry’s future. 6. BTFX – CoinShares Valkyrie Bitcoin Futures Leveraged Strategy ETF BTFX seeks to achieve 2x daily Bitcoin index returns via Bitcoin futures contracts also made it to the list with nearly 16% returns in the last week. 7. BITX – 2X Bitcoin Strategy ETF BITX, which seeks daily investment results, before fees and expenses, that correspond to two times the excess return of the S&P CME Bitcoin Futures Daily Roll Index, was another crypto-fund on the list of leveraged ETFs with over 15% returns last week. 8. MSTX – Defiance Daily Target 2x Long MSTR ETF MSTX seeks to provide 2x leveraged exposure to the daily share price movement of MicroStrategy Incorporated (NYSE: MSTR)was present on the list. The stock got a boost driven by its profitable Bitcoin investments and a recent partnership with a leading technology firm, which is set to enhance its product offerings and market reach. 9. BZQ – ProShares Ultrashort MSCI Brazil Capped ETF The BZQ ETF offers a good way to play the bearish short-term outlook for Brazilian large-cap stocks. This inverse ETF returned more than 12% in the last week. Brazil’s stock market fell last week, pulled down by its financial sector, after President Trump imposed 50% tariffs on Brazilian imports, citing political disputes. 10. AGQ – Proshares Ultra Silver AGQ ETF, which offers 2x daily long leverage to the Silver bullion, returned ~11.5% last week. The silver ETF gained after finally crossing the resistance level last month. Safe-haven buying amidst global uncertainties and increasing investor interest also supported the silver price. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.